Skip to main content
logo
Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
33.49
-0.28 (-0.83%)
Jul 20, 2026, 4:00 PM EDT - Market closed

HRMY Revenue

Harmony Biosciences Holdings had revenue of $215.39M in the quarter ending March 31, 2026, with 16.59% growth. This brings the company's revenue in the last twelve months to $899.11M, up 20.71% year-over-year. In the year 2025, Harmony Biosciences Holdings had annual revenue of $868.45M with 21.51% growth.

Revenue (ttm)
$899.11M
Revenue Growth
+20.71%
P/S Ratio
2.20
Revenue / Employee
$3,068,625
Employees
293
Market Cap
1.94B

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025868.45M153.72M21.51%
Dec 31, 2024714.73M132.71M22.80%
Dec 31, 2023582.02M144.17M32.93%
Dec 31, 2022437.86M132.42M43.35%
Dec 31, 2021305.44M145.70M91.21%
Dec 31, 2020159.74M153.75M2,564.59%
Dec 31, 20196.00M--
Dec 31, 2018---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Lakefront Biotherapeutics NV1.20B
ADMA Biologics509.86M
UroGen Pharma140.49M
AbCellera Biologics79.21M
Viridian Therapeutics70.92M
Ocular Therapeutix52.04M
Nanobiotix38.27M
Taysha Gene Therapies7.47M
Revenue Rankings

HRMY News

More News